IgE antibody against surface antigens of Leishmania promastigotes in American cutaneous leishmaniasis.
As IgE-mediated immune mechanisms participate in the host defence against some types of parasites, we evaluated sera from American cutaneous leishmaniasis (ACL) patients for the presence of this antibody against Leishmania. Using monoclonal antibodies against human IgE and an immunoperoxidase staining technique, 48% of the patients sera tested were found to contain IgE antibody that bound strongly to Leishmania promastigotes. A much lower proportion of sera from non-symptomatic subjects from either endemic or non-endemic areas of the disease contained significant levels of anti-Leishmania IgE antibody (6.5% and 0% respectively). The results indicated that the IgE antibody bound predominantly to surface components of the promastigotes, and reactivity against the intracellular amastigote form of the parasite was rarely detected. Somewhat unexpectedly, in a small proportion of the sera, the IgE antibody showed apparent specificity for L. mexicana or L. braziliensis. This study demonstrates that ACL patients can develop anti-Leishmania IgE antibody responses, that seem to be directed preferentially against surface antigens of promastigotes, and that can be strain specific. This raises the question as to the possible contribution of this antibody to the immune defence mechanisms against the parasite.
D000818:Animals; D000953:Antigens, Protozoan / Q000276:immunology*; D006801:Humans; D006967:Hypersensitivity / Q000276:immunology; D007124:Immunoenzyme Techniques; D007073:Immunoglobulin E / Q000276:immunology*; D007891:Leishmania / Q000276:immunology*; D007892:Leishmania braziliensis / Q000276:immunology; D007894:Leishmania mexicana / Q000276:immunology; D007896:Leishmaniasis / Q000276:immunology*; D007897:Leishmaniasis, Mucocutaneous / Q000276:immunology
D000953:Antigens, Protozoan; D007073:Immunoglobulin E